Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
First Claim
Patent Images
1. A method for alleviating fatigue arising from an oncological condition, said method comprising the steps of:
- identifying a patient suffering from said fatigue, and administering to said patient a therapeutically effective amount of D-threo-methylphenidate substantially free of the 1-threo isomer.
0 Assignments
0 Petitions
Accused Products
Abstract
In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising
45 Citations
46 Claims
-
1. A method for alleviating fatigue arising from an oncological condition, said method comprising the steps of:
-
identifying a patient suffering from said fatigue, and administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (2, 3, 4, 41)
-
-
5. A method for alleviating fatigue arising from the administration of a treatment for an oncological condition, said method comprising the steps of:
-
identifying a patient suffering from said fatigue, and administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (6, 7, 8, 9, 10, 20, 42)
-
-
11. A method for alleviating neurobehavioral slowing arising from an oncological condition, said method comprising the steps of:
-
identifying a patient suffering from said neurobehavioral slowing, and administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (12, 13, 14, 43)
-
-
15. A method for alleviating neurobehavioral slowing arising from the administration of a treatment for an oncological condition, said method comprising the steps of:
-
identifying a patient suffering from said neurobehavioral slowing, and administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (16, 17, 18, 19, 44)
-
-
21. A method for alleviating a cognitive side effect of a treatment for an oncological condition, comprising the steps of:
-
identifying a patient suffering from a cognitive side-effect of a treatment for an oncological condition; and
administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 29, 30, 45)
-
-
31. A method for treating a symptom of menopause comprising the steps of:
-
identifying a patient suffering from a symptom of menpoause; and
administering to said patient a therapeutically effective amount of D -threo-methylphenidate substantially free of the 1-threo isomer. - View Dependent Claims (32, 33, 34, 35, 36, 37, 38, 39, 40, 46)
-
Specification